Quit smoking and vaping together or one at a time? small study seeks answers
NCT ID NCT06027840
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether quitting cigarettes and e-cigarettes at the same time or one after the other is more effective. Nineteen adults who smoked and vaped received varenicline (a medication to reduce cravings) and counseling. Researchers measured abstinence and health markers at 12 weeks. The goal is to find the best strategy for dual users to quit both products.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Varenicline (a medication to reduce cravings) and behavioral counseling
- What this could lead to
- If successful, this could help people who both smoke and vape find the best way to quit both products for good.
- What could go wrong
- This is a very small, early-phase study with only 19 participants, so results may not apply to everyone. The medication varenicline can cause side effects like nausea or sleep issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale University
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- Could a pyramid-shaped workout help smokers breathe easier?
- Talking it out: could a Conversation-Based approach curb smoking in future nurses?
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Free meds could boost quit rates in stroke survivors